PMID- 34979254 OWN - NLM STAT- MEDLINE DCOM- 20220428 LR - 20220428 IS - 1872-9738 (Electronic) IS - 0892-0362 (Linking) VI - 90 DP - 2022 Mar-Apr TI - Neurobehavioral and neurochemical effects of perinatal arsenite exposure in Sprague-Dawley rats. PG - 107059 LID - S0892-0362(21)00113-6 [pii] LID - 10.1016/j.ntt.2021.107059 [doi] AB - Exposure to relatively high levels of inorganic arsenic (iAs) is associated with detrimental effects on human health, including cancer and diabetes. The effects of lower-level exposures are less clear, and gaps in the literature exist as to the effects of iAs exposure on neurodevelopment. The current study assessed the effects of perinatal iAs exposure on rodent neurodevelopment and behavior. Pregnant Sprague-Dawley (SD) rats were exposed to arsenite (AsIII) via oral gavage on gestational days (GD) 6 through 21, and pups were directly dosed via gavage on postnatal days (PND) 1 through 21. Dams and offspring received the same doses: 0.00, 0.10, 1.50, or 3.75 mg/kg/day. Male and female offspring underwent a battery of behavioral assessments from weaning until PND 180. Brain arsenic levels increased in a dose-dependent manner at both PND 1 and 21. Results from the behavioral tests show that pre- and postnatal AsIII exposure did not adversely affect offspring weight gain, adolescent motor and cognitive functions, or adult motor and cognitive functions in the SD rat. There were no differences in concentration of several brain proteins associated with blood-brain barrier permeability, dopamine functions, and inflammation. CI - Published by Elsevier Inc. FAU - Flanigan, Timothy J AU - Flanigan TJ AD - Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, AR 72079, United States of America. FAU - Ferguson, Sherry A AU - Ferguson SA AD - Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, AR 72079, United States of America. FAU - Law, Charles D AU - Law CD AD - Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, AR 72079, United States of America. FAU - Rosas-Hernandez, Hector AU - Rosas-Hernandez H AD - Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, AR 72079, United States of America. FAU - Cuevas-Martinez, Elvis AU - Cuevas-Martinez E AD - Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, AR 72079, United States of America. FAU - Fitzpatrick, Suzanne AU - Fitzpatrick S AD - Office of the Center Director, Center for Food Safety and Applied Nutrition/FDA, , United States of America. FAU - Shen, Andrew N AU - Shen AN AD - Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, AR 72079, United States of America. Electronic address: Andrew.Shen@fda.hhs.gov. LA - eng PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20211231 PL - United States TA - Neurotoxicol Teratol JT - Neurotoxicology and teratology JID - 8709538 RN - 0 (Arsenites) RN - N712M78A8G (Arsenic) SB - IM MH - Animals MH - *Arsenic MH - *Arsenites/metabolism/toxicity MH - Behavior, Animal MH - Brain MH - Female MH - Humans MH - Male MH - Pregnancy MH - *Prenatal Exposure Delayed Effects/chemically induced/metabolism MH - Rats MH - Rats, Sprague-Dawley OTO - NOTNLM OT - Developmental toxicity OT - Inorganic arsenic OT - Neurobehavioral assessment EDAT- 2022/01/04 06:00 MHDA- 2022/04/29 06:00 CRDT- 2022/01/03 20:14 PHST- 2021/08/17 00:00 [received] PHST- 2021/12/13 00:00 [revised] PHST- 2021/12/15 00:00 [accepted] PHST- 2022/01/04 06:00 [pubmed] PHST- 2022/04/29 06:00 [medline] PHST- 2022/01/03 20:14 [entrez] AID - S0892-0362(21)00113-6 [pii] AID - 10.1016/j.ntt.2021.107059 [doi] PST - ppublish SO - Neurotoxicol Teratol. 2022 Mar-Apr;90:107059. doi: 10.1016/j.ntt.2021.107059. Epub 2021 Dec 31.